News Desk: Industry Responds to Warning Letters on DMBA

FDA recently issued 14 warning letters to supplement companies selling products containing DMBA, a potentially harmful stimulant. The administration ordered the companies to discontinue distribution of these products immediately. FDA declared it will take additional action if the potentially dangerous DMBA-containing products are not taken off of the market. Watch this INSIDER News Desk for more coverage, and also check out regulatory editor Josh Long's post, "FDA Issues 14 Warning Letters on DMBA to Supplement Companies," for a full report of the event.